- Home
- ETV vs CERT Comparison
ETV vs CERT Comparison
Compare ETV & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ETV
- CERT
- Stock Information
- Founded
- ETV 2005
- CERT 2008
- Country
- ETV United States
- CERT United States
- Employees
- ETV N/A
- CERT N/A
- Industry
- ETV Investment Managers
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- ETV Finance
- CERT Technology
- Exchange
- ETV Nasdaq
- CERT Nasdaq
- Market Cap
- ETV 1.7B
- CERT 1.9B
- IPO Year
- ETV N/A
- CERT 2020
- Fundamental
- Price
- ETV $14.31
- CERT $12.90
- Analyst Decision
- ETV
- CERT Buy
- Analyst Count
- ETV 0
- CERT 8
- Target Price
- ETV N/A
- CERT $15.43
- AVG Volume (30 Days)
- ETV 252.5K
- CERT 2.0M
- Earning Date
- ETV 01-01-0001
- CERT 11-05-2025
- Dividend Yield
- ETV 8.75%
- CERT N/A
- EPS Growth
- ETV N/A
- CERT N/A
- EPS
- ETV N/A
- CERT 0.05
- Revenue
- ETV N/A
- CERT $405,755,000.00
- Revenue This Year
- ETV N/A
- CERT $11.71
- Revenue Next Year
- ETV N/A
- CERT $8.14
- P/E Ratio
- ETV N/A
- CERT $271.10
- Revenue Growth
- ETV N/A
- CERT 11.61
- 52 Week Low
- ETV $11.05
- CERT $8.64
- 52 Week High
- ETV $13.50
- CERT $15.69
- Technical
- Relative Strength Index (RSI)
- ETV 63.22
- CERT 61.01
- Support Level
- ETV $14.06
- CERT $13.01
- Resistance Level
- ETV $14.32
- CERT $13.88
- Average True Range (ATR)
- ETV 0.13
- CERT 0.54
- MACD
- ETV 0.01
- CERT 0.15
- Stochastic Oscillator
- ETV 87.56
- CERT 63.45
About ETV Eaton Vance Corporation Eaton Vance Tax-Managed Buy-Write Opportunities Fund of Beneficial Interest
Eaton Vance Tax-Managed Buy-Write Opp is a United States-based diversified, closed-end management investment company. Its primary investment objective is to provide current income and gains. The secondary objective of the fund is capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in a diversified portfolio of common stocks, designated segments of which seek to exceed the total return performance of the S&P 500 and the NASDAQ-100.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.